NEW YORK (GenomeWeb) – CareDx today announced that its European distributor of AlloMap tests, Diaxonhit, has signed a service sub-licensing agreement with the Strasbourg University Hospitals to perform all AlloMap testing at a dedicated facility in Strasbourg, France.

Diaxonhit is the exclusive distributor of AlloMap in Europe. The blood-based molecular diagnostic test allows clinicians to monitor heart transplant recipients for acute cellular rejection.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.